Was tun bei therapierefraktärem diabetischen Makulaödem nach anti-VEGF loading dosis? Fortsetzung der anti-VEGF Therapie versus früher Wechsel zu Dexamethason Implantat – Real-Life Daten.
| dc.contributor.author | Chabblani, Jay | |
| dc.contributor.author | Hindi, Isaac | |
| dc.contributor.author | Agrawal, Kushal | |
| dc.contributor.author | Lowenstein, Anat | |
| dc.contributor.author | Rehak, Matus | |
| dc.contributor.author | Busch, Catharina | |
| dc.contributor.author | Iglicki, Matias | |
| dc.contributor.author | Zur, Dinah | |
| dc.contributor.author | Fraser-Bell, Samantha | |
| dc.contributor.author | Lains, Ines | |
| dc.contributor.author | Santos, Ana Rita | |
| dc.contributor.author | Lupidi, Marco | |
| dc.contributor.author | Cagini, Carlo | |
| dc.contributor.author | Gabriel, Pierre-Henry | |
| dc.contributor.author | Couturier, Aude | |
| dc.contributor.author | Mané-Tauty, Valerie | |
| dc.contributor.author | Giancopoli, Ermete | |
| dc.contributor.author | D’Amico Ricci , Giuseppe | |
| dc.contributor.author | Cebeci, Zafer | |
| dc.contributor.author | Rodríguez-Valdés , Patricio J | |
| dc.contributor.author | Chaikitmongkol, Voraporn | |
| dc.contributor.author | Amphornphruet, Atchara | |
| dc.date.accessioned | 2021-12-10T12:29:06Z | |
| dc.date.available | 2021-12-10T12:29:06Z | |
| dc.identifier.citation | Busch C., Iglicki M., Zur D., Fraser-Bell S., Lains I., Santos A. R. , Lupidi M., Cagini C., Gabriel P., Couturier A., et al., "Was tun bei therapierefraktärem diabetischen Makulaödem nach anti-VEGF loading dosis? Fortsetzung der anti-VEGF Therapie versus früher Wechsel zu Dexamethason Implantat – Real-Life Daten.", DOG 2018, Bonn, Almanya, 27 - 30 Eylül 2018, ss.68 | |
| dc.identifier.other | vv_1032021 | |
| dc.identifier.other | av_bfacd740-9cec-4977-8103-315e9306d6ae | |
| dc.identifier.uri | http://hdl.handle.net/20.500.12627/173983 | |
| dc.language.iso | eng | |
| dc.subject | Klinik Tıp (MED) | |
| dc.subject | Sağlık Bilimleri | |
| dc.title | Was tun bei therapierefraktärem diabetischen Makulaödem nach anti-VEGF loading dosis? Fortsetzung der anti-VEGF Therapie versus früher Wechsel zu Dexamethason Implantat – Real-Life Daten. | |
| dc.type | Bildiri | |
| dc.contributor.department | , , | |
| dc.contributor.firstauthorID | 2645509 |
Files in this item
| Files | Size | Format | View |
|---|---|---|---|
|
There are no files associated with this item. |
|||
This item appears in the following Collection(s)
-
Bildiri [64839]
